Ken Griffin Treace Medical Concepts, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $8.45 $5,010 - $8,450	1,000 Added 0.76%	131,800 $764,000
Q2 2024 Aug 14, 2024	SELL	$4.17 - $12.62 $103,833 - $314,238	-24,900 Reduced 15.99%	130,800 $869,000
Q1 2024 May 15, 2024	BUY	$11.48 - $15.86 $1.34 Million - $1.84 Million	116,300 Added 295.18%	155,700 $2.03 Million
Q4 2023 Feb 14, 2024	BUY	$6.03 - $12.88 $80,199 - $171,304	13,300 Added 50.96%	39,400 $502,000
Q3 2023 Nov 14, 2023	BUY	$12.16 - $24.87 $1,216 - $2,487	100 Added 0.38%	26,100 $342,000
Q2 2023 Aug 14, 2023	SELL	$23.91 - $27.81 $1.95 Million - $2.27 Million	-81,600 Reduced 75.84%	26,000 $665,000
Q1 2023 May 15, 2023	BUY	$20.23 - $26.22 $900,235 - $1.17 Million	44,500 Added 70.52%	107,600 $2.71 Million
Q4 2022 Feb 14, 2023	SELL	$20.54 - $24.67 $151,996 - $182,558	-7,400 Reduced 10.5%	63,100 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$14.71 - $24.18 $826,702 - $1.36 Million	-56,200 Reduced 44.36%	70,500 $1.56 Million

138

39.7M

352K

269K

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $436M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.